NAPROXEN
- Product NDC
- 68788-6998
- 11-digit product format
- 687886998
- Labeler code
- 68788
- Product ID
- 68788-6998_70c2b823-bb42-46fa-b8b2-675fe6abb207
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2017-07-24
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-6998-1 | EA - Each | 68788-6998 | 31c93518-7d22-46ec-a607-958f3b48af3e | 1 | 2018-08-13 |
| 68788-6998-2 | EA - Each | 68788-6998 | 922ce48c-d2c7-4841-94fe-8138abcd0526 | 1 | 2018-08-13 |
| 68788-6998-3 | EA - Each | 68788-6998 | 02dce508-8ca4-4c73-aaee-2204799f6e9f | 1 | 2018-08-13 |
| 68788-6998-4 | EA - Each | 68788-6998 | 27f0c89c-0a28-4030-9a2e-e9f77a79aea9 | 1 | 2018-08-13 |
| 68788-6998-5 | EA - Each | 68788-6998 | a0452ffd-d1cf-4f42-88ae-5cbcc9ee9bbc | 1 | 2018-08-13 |
| 68788-6998-6 | EA - Each | 68788-6998 | c6158dc2-d1a6-4622-8185-75b64f13ee65 | 1 | 2018-08-13 |
| 68788-6998-7 | EA - Each | 68788-6998 | 312a4fcb-c478-442c-a82f-8dff579629fa | 1 | 2018-08-13 |
| 68788-6998-8 | EA - Each | 68788-6998 | cdd1c762-9610-4528-b1d6-ca3a2fcee843 | 1 | 2018-08-13 |
| 68788-6998-9 | EA - Each | 68788-6998 | 878f08a0-a85f-4b3a-b549-ecc658afd3fb | 1 | 2018-08-13 |